Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital ...
Disease-associated vision changes are common in GCA, with no significant difference in visual improvement observed with IV glucocorticoids vs oral therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback